BioMarin Pharmaceutical Inc. (VIE:BMRN)

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	10,135	9,807	10,788	15,646	16,584	13,980
Market Cap Growth	-19.11%	-9.10%	-31.05%	-5.66%	18.63%	1.96%
Enterprise Value	9,344	8,978	10,322	15,657	16,405	14,036
PE Ratio	34.11	33.02	29.74	110.83	137.99	-252.43
Forward PE	10.99	12.37	17.86	38.98	39.00	85.79
PEG Ratio	-	0.65	0.72	1.07	0.86	2.66
PS Ratio	3.69	3.54	4.39	7.52	9.20	8.80
PB Ratio	1.95	1.87	2.22	3.67	4.19	3.81
P/TBV Ratio	1.66	1.93	2.29	3.73	4.25	3.79
P/FCF Ratio	16.41	15.72	25.72	290.64	350.82	77.76
P/OCF Ratio	14.37	13.77	21.89	114.18	109.58	53.36
EV/Sales Ratio	3.36	3.24	4.20	7.52	9.10	8.84
EV/EBITDA Ratio	14.76	21.34	20.66	62.72	72.51	634.83
EV/EBIT Ratio	16.65	25.48	24.77	97.96	118.45	-198.13
EV/FCF Ratio	15.13	14.39	24.61	290.85	347.02	78.07
Debt / Equity Ratio	0.10	0.10	0.11	0.22	0.24	0.25
Debt / EBITDA Ratio	1.22	1.22	1.02	3.75	4.12	41.99
Debt / FCF Ratio	0.82	0.82	1.22	17.37	19.71	5.16
Net Debt / Equity Ratio	-0.16	-0.16	-0.10	0.00	-0.04	0.02
Net Debt / EBITDA Ratio	-1.97	-1.97	-0.93	0.05	-0.79	2.54
Net Debt / FCF Ratio	-1.33	-1.33	-1.11	0.21	-3.79	0.31
Asset Turnover	0.44	0.44	0.41	0.37	0.34	0.31
Inventory Turnover	0.57	0.57	0.50	0.53	0.60	0.64
Quick Ratio	3.25	3.25	2.96	1.45	2.98	2.54
Current Ratio	5.21	5.21	5.33	2.51	4.67	4.16
Return on Equity (ROE)	5.94%	5.94%	8.05%	3.51%	3.19%	-1.53%
Return on Assets (ROA)	4.06%	4.06%	5.52%	2.50%	2.46%	-1.18%
Return on Invested Capital (ROIC)	5.63%	5.63%	7.39%	3.44%	3.38%	-1.59%
Return on Capital Employed (ROCE)	6.20%	6.20%	8.04%	3.24%	2.86%	-1.52%
Earnings Yield	2.93%	3.03%	3.36%	0.90%	0.72%	-0.40%
FCF Yield	6.09%	6.36%	3.89%	0.34%	0.29%	1.29%
Buyback Yield / Dilution	0.36%	0.36%	0.23%	0.04%	-0.08%	-0.02%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.